Industry News

The Industry News page consists of Industry Spotlights, Pre-Event Newsletters, Post-Event Reports, Whitepapers and Vendor News.

Industry Spotlight
Here, we speak to UT Southwestern’s Shuang Liang about monitoring TREM2 as a non-invasive diagnostic biomarker for NASH.
Edited by Ben Norris |
17 November 2023
Biomarkers for Clinical Development
Industry Spotlight
A recent FNIH study demonstrates the effectiveness of non-invasive blood tests in diagnosing non-alcoholic steatohepatitis (NASH), potentially reducing the need for invasive liver biopsies and improving NASH diagnosis.
Edited by Ben Norris |
07 November 2023
Biomarkers for Clinical Development
Industry Spotlight
Digital biomarkers hold promise for healthcare, offering improved rare disease detection and cost reduction, with the potential for future implementation in clinical healthcare settings.
Edited by Ben Norris |
23 October 2023
Digital Biomarkers & Digital Pathology
Industry Spotlight
Digital pathology could enable the integration of biomarkers to enhance therapy effectiveness, potentially improving the capabilities of pathologists through AI-powered tools.
Edited by Ben Norris |
12 October 2023
Digital Biomarkers & Digital Pathology
Whitepaper
12 October 2023
Biomarker Technologies
Whitepaper
12 October 2023
Biomarker Technologies
Whitepaper
12 October 2023
Biomarker Technologies
Whitepaper
12 October 2023
Biomarker Technologies
Whitepaper
12 October 2023
Biomarkers Series, Biomarker Technologies
Whitepaper
12 October 2023
Biomarker Technologies
Advertisement